Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05712889 |
| Title | Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Vincerx Pharma, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Honor Health | RECRUITING | Scottsdale | Arizona | 85258 | United States | Details |
| NEXT Austin | RECRUITING | Austin | Texas | 78758 | United States | Details |
| NEXT Oncology San Antonio | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| Macquarie University | RECRUITING | Macquarie Park | New South Wales | 2109 | Australia | Details |
| ICON Brisbane | RECRUITING | Brisbane | Queensland | 4101 | Australia | Details |
| ICON Adelaide | RECRUITING | Adelaide | Southern Australia | 5037 | Australia | Details |